Long-term outcomes of treated chronic HCV compensated cirrhotic patients in Egypt

Abstract Background Hepatitis C virus (HCV) poses a major public health challenge in Egypt. Direct-acting antivirals (DAAs) are considered the optimal treatment for chronic HCV patients, given their high efficacy (sustained virologic response [SVR] > 90%) and minimal side effects. However, data on t...

Description complète

Détails bibliographiques

Auteurs principaux:	Omnia Tantawi, Eman Elsayed, Mohamed Abdallah, Wafaa ElAkel, Ahmed Fouad
Format:	Artigo
Langue:	Inglês
Publié:	SpringerOpen 2025-12-01
Collection:	Egyptian Liver Journal
Sujets:	Chronic HCV Liver Cirrhosis DAAs Long-term follow-up
Accès en ligne:	https://doi.org/10.1186/s43066-025-00485-1
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!